The Journal of Immunology, Vol 141, Issue 10 3416-3421, Copyright © 1988 by American Association of Immunologists

ARTICLES

IL-4 induces loss of B lymphocyte Fc gamma R II ligand binding capacity

G Laszlo and HB Dickler
Experimental Immunology Branch, National Cancer Institute, Bethesda, MD 20892.

Murine B lymphocytes cultured for 24 h with rIL-4 lost (mean reduction of 88%, range 81 to 96%) the capacity to bind Ag-IgG antibody complexes to B lymphocytes as assessed by flow microfluorometry. This effect was specific in that it was not seen with IL-1, IL-2, or IFN-gamma; IL-4 did not have a similar effect on other B lymphocyte membrane molecules; and the effect was completely prevented by anti-IL-4 (mAb 11B11). More than 60% inhibition of the binding of complexes was seen with as little as 1 U/ml of IL-4 although maximal inhibition was seen with greater than or equal to 30 U/ml. IL-4-induced inhibition of the binding of complexes was time dependent (the effect was first seen after 8 h and was not maximal until 24 h), temperature dependent (it did not occur at 4 degrees C), and reversible (B lymphocytes that had lost the ability to bind complexes due to IL-4 regained this capacity when re-cultured for 24 h in the absence of IL-4). The effect could be partially prevented by IFN-gamma. The inability to bind complexes appeared to be mainly due to an alteration of Fc gamma R (Fc Receptors) II rather than down-regulation of receptor expression because IL-4 induced only a moderate reduction in the binding of two Fc gamma R II specific mAb (20% for 2.4G2 and 32% for K9.361). The IL-4-induced loss of binding of complexes to B lymphocyte Fc gamma R II appears to be a novel form of receptor regulation (function rather than expression), and likely plays a role in the up-regulation of B lymphocytes by IL-4 by preventing Fc gamma R II-mediated inhibition of B lymphocyte responses.

This article has been cited by other articles:

				E. U. Rudge, A. J. Cutler, N. R. Pritchard, and K. G.C. Smith Interleukin 4 Reduces Expression of Inhibitory Receptors on B Cells and Abolishes CD22 and Fc{gamma}RII-mediated B Cell Suppression J. Exp. Med., April 15, 2002; 195(8): 1079 - 1085. [Abstract] [Full Text] [PDF]